bs-80517C
[Life Science]
Pranlukast
DATASHEET
Formulation powder
Storage: RT
Product Information:
Molecular Weight:481.51
Formula:C27H23N5O4
Purity:>98%
Solubility:Soluble in DMSO (up to 25 mg/ml)
Chemical Name:N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide
Formula:C27H23N5O4
Purity:>98%
Solubility:Soluble in DMSO (up to 25 mg/ml)
Chemical Name:N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide
Description:
Pranlukast is a selective Leukotriene CysLT1 antagonist1 and has been used in the treatment of asthma2. Pranlukast is also an inhibitor of GPR173 (IC50’s = 10.5nM hGPR17, 31nM rGPR17) and is superior to Montelukast in achieving functional inhibition4.
Size: 50 mg, 250 mg50 mg, 250 mg
Applications: Life Science()
For research use only. Not intended for diagnostic or therapeutic use.